Resonance Health Files Provisional Patent
- 20 November 2019
Resonance Health is pleased to announce that it has filed a provisional patent for the discovery and use of novel blood markers to determine an individual’s iron status. These blood markers have been identified as part of the Company’s molecular medicine R&D program.
International Thalassaemia Day
- 08 May 2019
International Thalassaemia Day is a very special day that commemorates thalassemia patients everywhere.
Resonance Health News - April 2019
- 29 April 2019
Resonance Health is delighted to provide you with our latest customer newsletter where you can find an update on all our latest acitvities.
To read the newsletter please click here
Distribution Agreement with EnvoyAI
- 15 January 2019
Resonance Health is pleased to announce that it has entered into a Distribution Agreement with EnvoyAI for the distribution of the Company’s FerriSmart® product, which recently received FDA regulatory clearance.
FDA Clearance Granted for FerriSmart
- 03 December 2018
Resonance Health is please to announce that it has received 510(k) clearance from the US Food and Drug Administration for FerriSmart®, the Company's ground-breaking machine learning solution for the quantification of liver iron concentration.
TGA, CE Mark clearance for A.I. Solution FerriSmart
- 11 July 2018
Resonance Health is pleased to announce that FerriSmart®, its groundbreaking AI solution for the quantification of liver iron concentration (LIC), has now achieved TGA and CE Mark clearance, making it the only regulatory approved artificial intelligence tool for use in liver iron quantification.